PT Kimia Farma (Persero) Tbk
KAEF
Rank in Stocks
#19251
PT Kimia Farma (Persero) Tbk, an Indonesian entity, is engaged in the... PT Kimia Farma (Persero) Tbk, an Indonesian entity, is engaged in the manufacturing and sale of a diverse range of products, including pharmaceuticals, herbal remedies, iodine, salts, quinine and its derivatives, and vegetable oils. Its business operations are structured across several key divisions: Manufacturing, Distribution, Retail, and Other Services. Beyond these, the company's portfolio extends to the production and sale of generic, ethical, licensed, and narcotic pharmaceuticals, along with over-the-counter drugs, medical equipment, raw materials, and cosmetics. Its extensive distribution network ensures products reach various outlets, including pharmacies, hospital pharmacies, medical centers, and drugstores. Established in 1817, the company maintains its headquarters in Jakarta, Indonesia.
Share Price
$0.01994211
Last synced: 2026-11-10
Market Cap
$111.01M
Change (1 day)
2.27%
Change (1 year)
-42.94%
Country
Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this
Trade PT Kimia Farma (Persero) Tbk (KAEF)
Category
Healthcare
Operating Margin for PT Kimia Farma (Persero) Tbk (KAEF)
Operating Margin as of November 2026 TTM: -1.95%
According to PT Kimia Farma (Persero) Tbk's latest financial reports, its current operating margin (TTM) is -1.95%. At the end of 2025 the company had an operating margin of -2.69%.
Operating Margin history for PT Kimia Farma (Persero) Tbk from 2008 to 2026
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2026 (TTM) | -1.95% | -27.51% |
| 2025 | -2.69% | -67.03% |
| 2024 | -8.16% | -48.22% |
| 2023 | -15.76% | -392.94% |
| 2022 | 5.38% | -29.86% |
| 2021 | 7.67% | 17.46% |
| 2020 | 6.53% | 22.28% |
| 2019 | 5.34% | -47.95% |
| 2018 | 10.26% | 17.39% |
| 2017 | 8.74% | 14.70% |
| 2016 | 7.62% | -1.04% |
| 2015 | 7.70% | 1.58% |
| 2014 | 7.58% | 12.13% |
| 2013 | 6.76% | -11.52% |
| 2012 | 7.64% | 19.75% |
| 2011 | 6.38% | 39.00% |
| 2010 | 4.59% | 17.09% |
| 2009 | 3.92% | -1.01% |
| 2008 | 3.96% | 0.00% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin Difference | Country |
|---|---|---|---|
| 1.62% | -100.83% |
US
|
|
| 1.30% | -100.67% |
US
|
|
| 1.03% | -100.53% |
US
|
|
| 0.91% | -100.47% |
US
|
|
| 9.21% | -104.72% |
AU
|
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.
Questions about PT Kimia Farma (Persero) Tbk's operating margin
What is PT Kimia Farma (Persero) Tbk's operating margin?
PT Kimia Farma (Persero) Tbk's operating margin is -1.95%, as of Nov 2026.
What was PT Kimia Farma (Persero) Tbk's operating margin in 2025?
In 2025, PT Kimia Farma (Persero) Tbk's operating margin was -2.69%, compared with -8.16% in 2024.
How has PT Kimia Farma (Persero) Tbk's operating margin changed since 2020?
From 2020 to 2025, PT Kimia Farma (Persero) Tbk's operating margin was highest in 2021 (7.67%) and lowest in 2023 (-15.76%).
How does PT Kimia Farma (Persero) Tbk's operating margin compare with similar companies?
PT Kimia Farma (Persero) Tbk's operating margin (-1.95%) is lower than that of all 5 similar companies listed above. The highest among them is Sigma Healthcare Limited, with 9.21%.